PMC:7252096 / 6630-6896 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T99909","span":{"begin":28,"end":33},"obj":"Body_part"}],"attributes":[{"id":"A81429","pred":"fma_id","subj":"T99909","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T60","span":{"begin":132,"end":140},"obj":"Disease"},{"id":"T61","span":{"begin":132,"end":136},"obj":"Disease"}],"attributes":[{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T86762","span":{"begin":15,"end":20},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T39988","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T29","span":{"begin":176,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"LitCovid-sentences","denotations":[{"id":"T40","span":{"begin":119,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"LitCovid-PubTator","denotations":[{"id":"245","span":{"begin":15,"end":20},"obj":"Species"},{"id":"246","span":{"begin":132,"end":140},"obj":"Species"}],"attributes":[{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:9606"},{"id":"A246","pred":"tao:has_database_id","subj":"246","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}

{"project":"2_test","denotations":[{"id":"32413319-25599080-20790436","span":{"begin":50,"end":54},"obj":"25599080"},{"id":"32413319-16860835-20790437","span":{"begin":72,"end":76},"obj":"16860835"},{"id":"32413319-15476870-20790438","span":{"begin":92,"end":96},"obj":"15476870"},{"id":"32413319-15296649-20790439","span":{"begin":112,"end":116},"obj":"15296649"},{"id":"32413319-26867177-20790440","span":{"begin":234,"end":238},"obj":"26867177"}],"text":"ent in primary human target cells (Bailey et al., 2014, de Lang et al., 2006, Sainz et al., 2004, Zheng et al., 2004). One study of SARS-CoV suggested the timing of the type I IFN response was critical in vivo (Channappanavar et al., 2016). Clinical therapy using ap"}